Tag: Rare disease company
Takeda offers $62bn to acquire Irish rare disease company Shire
Japanese pharma company Takeda Pharmaceutical has proposed to acquire Shire, an Ireland-based rare disease company for $62 billion after Botox-maker Allergan scrapped its plans of ... Read More